178 related articles for article (PubMed ID: 2827353)
41. Renal transplantation at Hartford Hospital: results of combined and flexible immunosuppression.
Schweizer RT; Bow L; Roper L; Hull D; Bartus SA
Clin Transpl; 1988; ():147-58. PubMed ID: 3154467
[TBL] [Abstract][Full Text] [Related]
42. Prevention of cytomegalovirus infection following bone marrow transplantation: a randomized trial of blood product screening.
Miller WJ; McCullough J; Balfour HH; Haake RJ; Ramsay NK; Goldman A; Bowman R; Kersey J
Bone Marrow Transplant; 1991 Mar; 7(3):227-34. PubMed ID: 1647829
[TBL] [Abstract][Full Text] [Related]
43. Cytomegalovirus infection in heart transplant recipients is associated with impaired endothelial function.
Petrakopoulou P; Kübrich M; Pehlivanli S; Meiser B; Reichart B; von Scheidt W; Weis M
Circulation; 2004 Sep; 110(11 Suppl 1):II207-12. PubMed ID: 15364864
[TBL] [Abstract][Full Text] [Related]
44. The transplanted kidney as a source of cytomegalovirus infection.
Ho M; Suwansirikul S; Dowling JN; Youngblood LA; Armstrong JA
N Engl J Med; 1975 Nov; 293(22):1109-12. PubMed ID: 171567
[TBL] [Abstract][Full Text] [Related]
45. Prophylaxis versus preemptive therapy for cytomegalovirus disease in high-risk liver transplant recipients.
Bodro M; Sabé N; Lladó L; Baliellas C; Niubó J; Castellote J; Fabregat J; Rafecas A; Carratalà J
Liver Transpl; 2012 Sep; 18(9):1093-9. PubMed ID: 22532316
[TBL] [Abstract][Full Text] [Related]
46. Diagnostic markers and risk factors of cytomegalovirus infection and disease in renal allograft recipients.
Hökeberg I; Eriksson BM; Zweygberg-Wirgart B; Tufvesson G; Olding-Stenkvist E; Grillner L
Scand J Infect Dis; 1995; 27(5):435-40. PubMed ID: 8588130
[TBL] [Abstract][Full Text] [Related]
47. The influence of mTOR inhibitors on the incidence of CMV infection in high-risk donor positive-recipient negative (D+/R-) kidney transplant recipients.
Cristelli MP; Esmeraldo RM; Pinto CM; Sandes-Freitas TV; Felipe C; Lobo CF; Viana L; Mansur J; Stopa S; Santos DWC; Grenzi PC; Aguiar WF; Tedesco-Silva H; Pestana JOM
Transpl Infect Dis; 2018 Aug; 20(4):e12907. PubMed ID: 29679515
[TBL] [Abstract][Full Text] [Related]
48. Impact of cytomegalovirus serology on graft survival in living related kidney transplantation: implications for donor selection.
Schnitzler MA; Woodward RS; Brennan DC; Spitznagel EL; Dunagan WC; Bailey TC
Surgery; 1997 May; 121(5):563-8. PubMed ID: 9142156
[TBL] [Abstract][Full Text] [Related]
49. Prevention of Late-Onset Cytomegalovirus Infection and Disease in Donor-Positive/Recipient-Negative Kidney Transplant Recipients Using Low-Dose Valganciclovir.
Nanmoku K; Shinzato T; Kubo T; Shimizu T; Kimura T; Yagisawa T
Transplant Proc; 2018; 50(1):124-129. PubMed ID: 29407294
[TBL] [Abstract][Full Text] [Related]
50. Transplanting kidneys from CMV-seropositive donors to CMV-seronegative recipients is not associated with poorer renal allograft function or survival.
McLaughlin K; Sandhu S; Wu C; Muirhead N; Hollomby D; Jevnikar A
Nephrol Dial Transplant; 2005 Jan; 20(1):176-80. PubMed ID: 15572381
[TBL] [Abstract][Full Text] [Related]
51. The influence of mycophenolate mofetil on the incidence and severity of primary cytomegalovirus infections and disease after renal transplantation.
ter Meulen CG; Wetzels JF; Hilbrands LB
Nephrol Dial Transplant; 2000 May; 15(5):711-4. PubMed ID: 10809816
[TBL] [Abstract][Full Text] [Related]
52. [Effectiveness of preemptive therapy with ganciclovir in recipients of renal transplants at high risk (R-/D+) for the development of cytomegalovirus disease].
Aranda-Verástegui F; Alberú J; Soto-Ramírez LE; González-Aguirre H; Muñoz Trejo T; Mancilla E; Díliz H; Correa-Rotter R; Sierra-Madero J
Rev Invest Clin; 2002; 54(3):198-203. PubMed ID: 12183888
[TBL] [Abstract][Full Text] [Related]
53. The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG-Study Group. Cytogam, MedImmune, Inc. Gaithersburg, Maryland.
George MJ; Snydman DR; Werner BG; Griffith J; Falagas ME; Dougherty NN; Rubin RH
Am J Med; 1997 Aug; 103(2):106-13. PubMed ID: 9274893
[TBL] [Abstract][Full Text] [Related]
54. A comparison of triple-therapy with double-therapy immunosuppression in cadaveric renal transplantation.
Bowman JS; Angstadt JD; Waymack JP; Jaffers GJ
Transplantation; 1992 Mar; 53(3):556-9. PubMed ID: 1312752
[TBL] [Abstract][Full Text] [Related]
55. Complications of cyclosporine-prednisone immunosuppression in 402 renal allograft recipients exclusively followed at a single center for from one to five years.
Kahan BD; Flechner SM; Lorber MI; Golden D; Conley S; Van Buren CT
Transplantation; 1987 Feb; 43(2):197-204. PubMed ID: 3544376
[TBL] [Abstract][Full Text] [Related]
56. Pharmacoepidemiology of cytomegalovirus prophylaxis in a large retrospective cohort of kidney transplant recipients with Medicare Part D coverage.
Santos CA; Brennan DC; Saeed MJ; Fraser VJ; Olsen MA
Clin Transplant; 2016 Apr; 30(4):435-44. PubMed ID: 26841129
[TBL] [Abstract][Full Text] [Related]
57. Impact of Cytomegalovirus Serostatus on Allograft Loss and Mortality Within the First Year After Kidney Transplantation: An Analysis of the National Transplant Registry.
Bruminhent J; Dajsakdipon T; Ingsathit A; Supaporn T; Prommool S; Watcharananan SP
Transplant Proc; 2020 Apr; 52(3):829-835. PubMed ID: 32113693
[TBL] [Abstract][Full Text] [Related]
58. A prospective randomized trial of prednisone versus no prednisone maintenance therapy in cyclosporine-treated and azathioprine-treated renal transplant patients.
Schulak JA; Mayes JT; Moritz CE; Hricik DE
Transplantation; 1990 Feb; 49(2):327-32. PubMed ID: 2407003
[TBL] [Abstract][Full Text] [Related]
59. Increased risk of breakthrough infection among cytomegalovirus donor-positive/recipient-negative kidney transplant recipients receiving lower-dose valganciclovir prophylaxis.
Stevens DR; Sawinski D; Blumberg E; Galanakis N; Bloom RD; Trofe-Clark J
Transpl Infect Dis; 2015 Apr; 17(2):163-73. PubMed ID: 25661673
[TBL] [Abstract][Full Text] [Related]
60. Acquisition of donor strains of cytomegalovirus by renal-transplant recipients.
Chou SW
N Engl J Med; 1986 May; 314(22):1418-23. PubMed ID: 3010114
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
